Two stocks that recently turned $1,000 into more than $5,000 over five years are Nvidia and Axon Enterprise. But it wasn't ...

Gilead Sciences faces revenue growth challenges as its blockbuster drugs lose exclusivity by 2033. Check out my ...

By Christine Chen (Reuters) -Australian biopharmaceutical company CSL said on Tuesday that falling immunisation rates in the ...

Affirm's strong Q2 results show market leadership, but risks include competition, credit quality, and valuation concerns.

The Medford-based, family owned contractor generated more than $800 million in revenue last year, a new record, per chief ...

Australian biopharmaceutical company CSL posted higher first-half profits as growth in its main blood-plasma business helped offset weaker flu vaccine sales, which were hit by "significantly" low ...

After several years of enormous growth in daily rates, revenue and occupancy, Phoenix’s hotel industry slowed down in 2024.

Philip Morris International is the world’s largest tobacco company by volume, with cigarette sales to roughly 170 countries. Despite such dominance, its goal is to completely replace its cigarette ...

S&P 500 companies' latest quarterly earnings and revenue growth rates have so far surpassed expectations, with the bottom-line results up by a double-digit percentage from a year earlier, Oppenheimer ...

Analysts have recently evaluated UDR and provided 12-month price targets. The average target is $46.43, accompanied by a high ...

SEI Investments consists of four main segments: private banks, investment advisors, institutional investors, and investment managers. A minority interest in value equity manager LSV Asset Management ...

In this article, we will take a detailed look at the Top 10 AI Stocks to Watch In February.